9229 Stock Overview
Operates nursing care business centered on PD house. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 6/6 |
| Past Performance | 6/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
Sunwels Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥948.00 |
| 52 Week High | JP¥3,095.00 |
| 52 Week Low | JP¥756.00 |
| Beta | 0 |
| 11 Month Change | -42.75% |
| 3 Month Change | -65.11% |
| 1 Year Change | -61.90% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 1.57% |
Recent News & Updates
Shareholder Returns
| 9229 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | -2.5% | -1.3% | -0.4% |
| 1Y | -61.9% | -6.5% | 11.4% |
Return vs Industry: 9229 underperformed the JP Healthcare industry which returned -6.5% over the past year.
Return vs Market: 9229 underperformed the JP Market which returned 11.4% over the past year.
Price Volatility
| 9229 volatility | |
|---|---|
| 9229 Average Weekly Movement | 16.1% |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 7.6% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 9229's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: 9229's weekly volatility has increased from 11% to 16% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 2,435 | Ryotatsu Nawashiro | sunwels.jp |
Sunwels Co.,Ltd. operates nursing care business centered on PD house. It operates homes for the elderly that specializes in Parkinson disease, as well as a Kaatsu training gym; provides day care, in-home care support, care plan, and home remodeling services; and operates medical specific facilities.
Sunwels Co.,Ltd. Fundamentals Summary
| 9229 fundamental statistics | |
|---|---|
| Market cap | JP¥28.74b |
| Earnings (TTM) | JP¥2.16b |
| Revenue (TTM) | JP¥23.37b |
13.3x
P/E Ratio1.2x
P/S RatioIs 9229 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9229 income statement (TTM) | |
|---|---|
| Revenue | JP¥23.37b |
| Cost of Revenue | JP¥16.42b |
| Gross Profit | JP¥6.95b |
| Other Expenses | JP¥4.79b |
| Earnings | JP¥2.16b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 71.07 |
| Gross Margin | 29.73% |
| Net Profit Margin | 9.22% |
| Debt/Equity Ratio | 95.9% |
How did 9229 perform over the long term?
See historical performance and comparison